Regen BioPharma, Inc. (RGBP)
OTCMKTS · Delayed Price · Currency is USD
0.0001
-0.00005 (-33.33%)
At close: Nov 9, 2026
Regen BioPharma Employees
Regen BioPharma had 1 employees as of September 30, 2024. The number of employees did not change compared to the previous year. That makes Regen BioPharma the 44,246th largest employer in the world and 7,496th in the United States.
Employees
1
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$236,560
Profits / Employee
-$1,186,180
Market Cap
167.53K
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2024 | 1 | 0 | - | 1 | 0 |
| Sep 30, 2023 | 1 | 0 | - | 1 | 0 |
| Sep 30, 2022 | 1 | -3 | -75.00% | 1 | 0 |
| Sep 30, 2018 | 4 | 0 | - | 1 | 3 |
| Sep 30, 2017 | 4 | 0 | - | 1 | 3 |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Lyra Therapeutics | 27 |
| Altamira Therapeutics | 11 |
| CERo Therapeutics Holdings | 8 |
| Ampio Pharmaceuticals | 6 |
| CNBX Pharmaceuticals | 1 |
| Actavia Life Sciences | 1 |
Regen BioPharma News
- 5 days ago - Regen BioPharma, Inc. Provides Shareholder Update on Company's Activities and Direction - GlobeNewsWire
- 1 year ago - Goldman Small Cap Research Publishes New Research Report on Regen BioPharma, Inc. - Accesswire
- 1 year ago - Regen BioPharma, Inc. Expands Vision for Phase 1 Clinical Trial of HemaXellerate™ - GlobeNewsWire
- 2 years ago - Regen BioPharma, Inc. to Present at the Emerging Growth Conference on September 25, 2024, At 4 pm Eastern Time - GlobeNewsWire
- 2 years ago - Regen BioPharma, Inc. to Present at the Emerging Growth Conference on May 9, 2024 - PRNewsWire
- 2 years ago - Regen BioPharma, Inc. to Discuss Plans to Move Forward with HemaXellerate into Clinical Phase 1 at the Emerging Growth Conference on April 4, 2024 - PRNewsWire
- 2 years ago - Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 7, 2024 - PRNewsWire
- 2 years ago - Regen BioPharma, Inc. to Present at the Emerging Growth Conference on February 7, 2024 - PRNewsWire